Global Planning to Local Execution Market Success
Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations [...]
Updated Promising Zone Design Improves Workflow and Clinical Trial Design for Biotechs
Promising Zone Design was first introduced a decade ago as a method to estimate sample size. The method is still [...]
Understanding the Power of Platform Trials
A recent Cytel blog post details the benefits of one category of the Master Protocol termed the platform trial, typically [...]
Cytel Statistician Discusses the Importance of Traceability in R&D Data Handling
Cytel’s Angelo Tinazzi discusses data traceability in a recent blog post. An expert in statistical programming and clinical data analysis, [...]
Cytel Researcher Discusses Deciding Between Progress Free Survival and Overall Survival Endpoints in Clinical Trials
Determining whether to use progress free survival (PFS) or overall survival (OS) in clinical trials is an important yet challenging [...]
New Cytel Whitepaper on Clinical Trial Optimization Using Pareto Efficiency
Cytel’s new whitepaper on optimizing clinical trial design discusses how to best allocate resources. Thoughtfully planning a clinical trial requires [...]
New Cytel Blog on Causal Inference and RWD in Decision Making
A new Cytel blog post discusses using real world data (RWD) to bypass phase IV clinical trials. In contrast to [...]
Cytel Strategist Discusses Clinical Trial Design and When to Include Interim Looks
Interim looks allow for sponsors of clinical trials to consider whether the trial should continue or if any modifications need [...]
Cytel’s Advances in RWD Include Comparative Effectiveness and Efficacy Assessments Using Target Trial Emulation Solution
Real world data (RWD) is attractive to many stakeholders as it offers a time- and cost-saving method to complement or [...]
Cytel Consultant Discusses Using Rolling-Enrollment to Speed Up Clinical Trials, Reduce Costs, and Improve Patient Safety
In the traditional clinical trial model, patients are enrolled in a clinical trial and then the effects of a treatment [...]
[Cytel Whitepaper] How Can RWE Drive Oncology Drug Development?
Cytel has published a whitepaper detailing how real world evidence (RWE) can be used in cancer drug development, from preclinical [...]
Part 2 of Cytel’s Webinar on Considerations for SCAs in Clinical Trials Now Available
A new webinar offered by Cytel details important considerations for researchers seeking to create synthetic control arms (SCAs) using real [...]
Cytel Paper on De-Risking Clinical Trials Using a Data-Driven Method
Cytel has published a position paper on using data to de-risk clinical trials. The paper discusses methods that can be [...]
Cytel Data Expert Discusses EHR Integration in Clinical Trials
Associate Director Business Development at Cytel and chair of the eDigital data management expert group Lauren Ellis-Hill discusses her thoughts [...]
Cytel Webinar on Understanding Synthetic Control Arms and Avoiding HTA Rejection
A recent Cytel webinar clarifies common misunderstandings regarding synthetic control arms (SCAs). The use of real world data (RWD) to [...]
Cytel Webinar on Clinical Trial Design Considerations for Sponsors
Cytel is offering an on-demand webinar that details key considerations for clinical trial sponsors. In addition to examining the downsides [...]
Cytel Article Highlights Common Clinical Trial Pitfalls and Solutions
Cytel has published a non-technical paper that highlights common statistical challenges that lead to sub-optimal clinical trial design. Study design [...]
Cytel Chief Data Officer Discuses HEOR and RWE
Cytel Chief Data Officer & Head of Europe Dr. Radek Wasiak discusses how Cytel has expanded to utilize health economics [...]
Cytel Blog on Applying Bayesian Methods to COVID-19 Clinical Trials
A Cytel blog post discusses how Bayesian methods have impacted COVID-19 vaccine clinical trials. Using Bayesian statistics can improve study [...]
Cytel Blog on Using Bayesian Methods to Improve Clinical Trials
A Cytel blog post discusses how using Bayesian methods can lead to several key benefits in clinical trial design, including [...]
Cytel Scientist Discusses Clinical Trial Statistical Success Strategies
Cytel scientist Dr. Yannis Jemiai discusses important statistical considerations critical for clinical trial success. Communication at all levels of the [...]
Cytel Webinar on Statistical Communication
The gap between statistics and decisions when it comes to modifying clinical trials continues to grow. Understanding when and how [...]
Webinar on RWE in Medical Device Trials Featuring FDA Statistician
Cytel’s new webinar is now available, featuring insight from former FDA statistician Dr. Ram Tiwari, now Head of Statistical Methodology [...]
Cytel Expands Access to Powerful Computational Solara Software, Will Reduce Clinical Trial Costs
Cytel decision-making software Solara has been opened for general release. It comes in two setups: one for companies with an [...]
High Powered Computational Tools Are Bringing Changes to Clinical Trial Design
As High-Performance Computing (HPC) becomes more widespread and accessible, even for relatively small companies, clinical trial design is expected to [...]